Literature DB >> 580521

Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism. II: Bone histomorphometry.

L Mosekilde, F Melsen.   

Abstract

Histomorphometric analysis of iliac crest biopsies was performed after tetracycline double-labelling in 22 hyperthyroid patients before and after medical antithyroid treatment for an average period of 4 months. The initially increased cortical porosity was normalized during treatment whereas the amount of trabecular bone was unchanged. The osteoclastic resorption in cortical bone decreased but was still elevated. The osteocytic osteolysis remained slightly increased. In trabecular bone, however, the bone turn-over decreased to a subnormal level following treatment and the surfaces were inactive in bone resorption and bone formation. An increase was observed in the amount, extent and width of osteoid seams due to an increase in the lifespan of bone forming sites and a prolongation of the maturity period of osteoid. The observed increased deposition of cortical bone after antithyroid treatment may explain the positive calcium balance in this period.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 580521     DOI: 10.1530/acta.0.0870751

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  11 in total

1.  Normalization of cortical bone density in children and adolescents with hyperthyroidism treated with antithyroid medication.

Authors:  N Numbenjapon; G Costin; P Pitukcheewanont
Journal:  Osteoporos Int       Date:  2011-12-21       Impact factor: 4.507

2.  Bone turnover in hyperthyroidism before and after thyrostatic management.

Authors:  G C Isaia; C Roggia; D Gola; M D Stefano; G Gallone; G Aimo; P Ardissone; M Mussetta
Journal:  J Endocrinol Invest       Date:  2000-12       Impact factor: 4.256

3.  Bone mineral density and bone microarchitecture after long-term suppressive levothyroxine treatment of differentiated thyroid carcinoma in young adult patients.

Authors:  Graziella Mendonça Monteiro de Barros; Miguel Madeira; Leonardo Vieira Neto; Francisco de Paula Paranhos Neto; Laura Maria Carvalho Mendonça; Inayá Corrêa Barbosa Lima; Rossana Corbo; Maria Lucia Fleiuss Farias
Journal:  J Bone Miner Metab       Date:  2015-06-09       Impact factor: 2.626

Review 4.  Bone physiology, disease and treatment: towards disease system analysis in osteoporosis.

Authors:  Teun M Post; Serge C L M Cremers; Thomas Kerbusch; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

5.  Effects of thyroxine on cortical bone remodeling in adult dogs: a histomorphometric study.

Authors:  W B High; C C Capen; H E Black
Journal:  Am J Pathol       Date:  1981-03       Impact factor: 4.307

6.  Effect of thyrotoxicosis and its treatment on mineral and bone metabolism.

Authors:  J D Lalau; J L Sebert; A Marie; A Fournier; J Quichaud
Journal:  J Endocrinol Invest       Date:  1986-12       Impact factor: 4.256

Review 7.  Role of Thyroid Hormones in Skeletal Development and Bone Maintenance.

Authors:  J H Duncan Bassett; Graham R Williams
Journal:  Endocr Rev       Date:  2016-02-10       Impact factor: 19.871

8.  Bone Indices in Thyroidectomized Patients on Long-Term Substitution Therapy with Levothyroxine Assessed by DXA and HR-pQCT.

Authors:  Emil Moser; Tanja Sikjaer; Leif Mosekilde; Lars Rejnmark
Journal:  J Thyroid Res       Date:  2015-07-13

9.  A Modest Protective Effect of Thyrotropin against Bone Loss Is Associated with Plasma Triiodothyronine Levels.

Authors:  Tae Hyuk Kim; Ji Young Joung; Mira Kang; Sun Kyu Choi; Kyunga Kim; Ju Young Jang; Yoon Young Cho; Yong-Ki Min; Jae Hoon Chung; Sun Wook Kim
Journal:  PLoS One       Date:  2015-12-17       Impact factor: 3.240

10.  Thyroid hormone receptor α mutation causes a severe and thyroxine-resistant skeletal dysplasia in female mice.

Authors:  J H Duncan Bassett; Alan Boyde; Tomas Zikmund; Holly Evans; Peter I Croucher; Xuguang Zhu; Jeong Won Park; Sheue-yann Cheng; Graham R Williams
Journal:  Endocrinology       Date:  2014-06-10       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.